Page 3 - Akeso Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC

Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesMichelle xiaAkeso incAmerican cancer societyInternational agency for research on cancerData monitoring committeeWorld health organizationPrnewswire akeso incJapan national cancer registryWas observed broadlyPatients across subgroupsExpressing tumorsData setUpcoming major medical conference plannedLater this

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesMenlo parkUnited kingdomCompensation committee onExchange commissionDrug administrationSummit therapeutics incAkeso incCompany compensation committeeSummit therapeuticsNasdaq listing ruleCompensation committeeNasdaq global marketPrivate securities litigation reform act

Head to Head Review: Universe Pharmaceuticals (NYSE:UPC) & Summit Therapeutics (NASDAQ:SMMT)

Summit Therapeutics (NASDAQ:SMMT – Get Free Report) and Universe Pharmaceuticals (NYSE:UPC – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, analyst recommendations, dividends, earnings and profitability. Profitability This table compares Summit Therapeutics and Universe […]

United statesUnited kingdomSummit therapeutics incAkeso incSununion holding groupUniverse pharmaceuticalsSummit therapeuticsGet free reportUniverse pharmaceuticalGiven summit therapeuticTherapeutics incSummit therapeutics daily

Akeso, Inc s New Cancer Drug Wins China Approval

Akeso, Inc. (HK:9926) has released an update. Akeso, Inc. has announced that its novel drug ivonescimab, designed for advanced lung cancer patients.

Akeso inc

RANKINGS: ALB Offshore Client Choice 2024 | Asian Legal Business

RANKINGS: ALB Offshore Client Choice 2024 | Asian Legal Business
legalbusinessonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from legalbusinessonline.com Daily Mail and Mail on Sunday newspapers.

Cay manCayman islandsBritish virgin islandsCity ofUnited kingdomXinzhu xianUniversity of hong kongHong kong generalHong kongNew zealandHelen wangOgier hong kongFlorence chanNathan powellRebecca leeAsia paci